跳至主要内容
临床试验/NCT03462277
NCT03462277已完成不适用

DNA Methylation and Hydroxymethylation Levels in Patients With Coronary Heart Disease

Chongqing Medical University1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2018年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
200
试验地点
1
主要终点
DNA Methylation and Hydroxymethylation Levels

研究概览

简要总结

The purpose of this trial is to investigate the relationship between DNA methylation and hydroxymethylation and the expression of DNMTs, TET family gene and the degree of coronary heart disease.

详细描述

  1. To determine the levels of DNA methylation and hydroxymethylation with coronary heart disease.
  2. To investigate the relationship between DNA methylation and hydroxymethylation and the degree of coronary atherosclerosis.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
65 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male and Female. Patients older than 65 years old who are willing to participate in the study. CHD patients was defined as at least one lesion in a coronary artery or branches in coronary angiograms. Control group was defined as people with negative findings in coronary angiograms.

排除标准

  • Patients with concurrent infection or any documented inflammatory illness, such as arthritis or connective tissue diseases, or any other malignancy. Patients with a history of cardiomyopathy. Pregnant women. Severe hepatic dysfunction or End-stage renal failure. Uncontrolled hypertension.

结局指标

主要结局

DNA Methylation and Hydroxymethylation Levels

时间窗: 1 month

Collection of blood samples and measuring the samples by PCR and ELISA

次要结局

未报告次要终点

研究者

发起方
Chongqing Medical University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Dongying Zhang

doctor

Chongqing Medical University

研究点 (1)

Loading locations...

相似试验

DNA Methylation and Hydroxymethylation Levels in... | 临床试验